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Pathogens often persist during infection because of antigenic variation, in which 
they evade immunity by switching between distinct surface antigen variants.  A 
central question is how ordered appearance of variants, an important determinant 
of chronicity, is achieved.  Theories suggest it results directly, from a complex 
pattern of transition connectivity between variants, or indirectly, from effects such 
as immune cross-reactivity or differential variant growth rates.  Using a 
mathematical model based only on known infection variables, we show that order in 
trypanosome infections can be explained more parsimoniously, by a simpler 
combination of two key, parasite-intrinsic factors: differential activation rates of 
parasite variant surface glycoprotein (VSG) genes, and density-dependent parasite 
differentiation.  The model outcomes concur with empirical evidence that several 
variants are expressed simultaneously and that parasitaemia peaks correlate with 
VSG genes within distinct activation probability groups.  Our findings provide a 
possible explanation for the enormity of the recently sequenced VSG silent archive 
and have important implications for field transmission. 
 
 3 
Trypanosomes switch antigens primarily by duplication of VSGs, in which the new 
gene copy replaces the expressed VSG.  There is a large archive of 1500-2000 silent 
VSGs from which to duplicate (1).  The VSG group activated with highest frequency are 
telomere-proximal, and they are duplicated via homologous gene flanks.  The second 
main group, located in subtelomeric arrays, are activated with relatively low frequency.  
This group mostly are pseudogenes, gene fragments or encode dysfunctional VSGs (1), 
but can be expressed as mosaic genes, through donation of segments of coding sequence 
from different VSGs (2).  A fundamental difference between these two archive groups is 
that the first switch independently of each other, duplicating via gene flanks, while the 
second group do not switch independently, as their duplication involves coding sequence 
homologies.   
Order in VSG expression could be imposed by the parasite or by indirect influences.  The 
most commonly proposed molecular basis for order (3-5) is that it operates through 
innate differences in the activation probability for VSGs, dependent on the flanking 
sequence homologies of the silent gene being activated or, for mosaic genes, degrees of 
homology between coding sequences of the incoming and outgoing VSG genes.  Indeed, 
the bacterium Anaplasma marginale, using an archival system, achieves differential 
switching via homologies in both gene flank and coding sequences (6).  There is 
empirical support for this general trypanosome molecular mechanism (7-14), and recent 
quantitative analysis has revealed a higher degree of order than previously supposed (15).  
Three studies in particular, together involving >100 variants in >50 infections, have 
firmly established order in VSG expression (15-17).  Most studies, however, have 
involved only single relapses, and therefore only a few high-probability switches, and it 
is important now to analyze long-term infection in greater detail, to help ascertain the 
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range and patterns of switch rates that can yield order, and how ordered expression 
interacts with trypanosome growth variables to yield the characteristic fluctuating 
parasitaemia.  One way to do so is to use mathematical modelling, based on known, 
major variables in trypanosome growth and antigenic variation. 
In contrast to the molecular hypothesis, most theoretical modelling studies have 
assumed a uniform switching pattern among variants (Fig. 1A) and invoked indirect 
effects to explain order.  There is, however, little empirical support for these other 
factors.  It has been proposed that order arises from variant-specific differences in 
intrinsic growth rates (18), but such an effect is, at best, insignificant (18, 19), and is not 
supported theoretically (20, 21).  Another possibility, that order arises from differential 
efficiencies of variant-specific immune responses, is negated by the observation that 
different variants are cleared in vivo by the immune system with closely similar dynamics 
(22).  The suggestion that transient expression of two VSGs by a trypanosome, such as 
during switching, could enhance sensitivity to antibodies and therefore influence order 
(21), is not supported by the normal in vivo growth and reduced immunogenicity of 
artificially created double expressors (23, 24).  Antigenic “cross-reactivity” based on 
common, invariant antigens (25, 26) is unlikely to cause order, because such molecules 
do not elicit protective responses against trypanosomes (27-29).  Order generated through 
VSGs sharing epitopes, corresponding to what has been proposed for PfEMP1 switching 
in the malaria parasite Plasmodium falciparum (30), is highly unlikely, because the 
degree of order observed would require multiple VSG cross-reactions, but these have 
been seen only for products of highly related VSG genes and in all cases cross-protection 
was complete (13, 31).  The cross-reactivity model proposed for malaria (30) depends on 
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transient antibody responses but, within the limits of available tests, they have not been 
detected in studies of trypanosome infections (15-17, 32). 
In light of the insights into the make-up of the VSG repertoire provided by the 
genome project (1), and in particular the emerging possibility that mosaic gene formation 
from pseudogenes makes a substantial contribution to antigenic variation, there is a 
requirement to revisit, and substantially revise, the existing modelling approaches to 
trypanosome VSG switching, and in particular to include differential VSG activation rates 
analogous to those seen in vivo.  Moreover, it is important to involve density-dependent 
parasite differentiation, a key growth parameter (33, 34) not previously incorporated into 
antigenic variation models.   
Of existing mathematical models, only one has addressed differential VSG 
activation rates and it successfully simulated ordered expression (35).  The model was 
based, however, on interdependent switching between variants, where the probability of 
switching on a particular variant (activation probability) depends on the currently 
expressed variant (Fig. 1B), and is associated with the direction of the switch, such that 
the probability of switching from variant i to variant j will not equal the probability of 
switching from variant j to variant i.  This assumption is not supported by empirical 
evidence that early switches are governed by the VSG being activated, rather than what is 
currently expressed (15), and that order early in infections is independent of the infecting 
variant (15-17, 22, 36).   
Given these data, a more plausible model is a differential-activation switching 
pattern during the early stage of infection (Fig. 1C), in which each variant has a distinct 
activation rate, independent of the currently expressed variant.  This pattern changes later 
in infection, when mosaic VSGs are expressed, because the involvement of coding 
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sequence homology in switching means that the variant being switched to does depend on 
the variant currently being expressed (Figure 1D).   
 
Trypanosome survival and growth in mammalian hosts, and the interplay between 
infection profile and antigenic variation, are complex, and it is important to incorporate 
variables that have been demonstrated to influence parasitaemia, and to exclude those of 
little or no biological relevance.  Factors known to exert significant influence on the 
course of infection include the density-dependent, parasite-triggered differentiation to the 
non-dividing short stumpy stage (33, 34), density-dependent general growth interference 
between trypanosomes (37) (which is likely to include any indirect immune system 
effects, such as reported in model host infections (38)), and the VSG-specific antibody 
responses.  All these have been quantified experimentally, permitting inclusion in 
mathematical modelling.   
 
Factors thought not to impact on the generation of ordered antigenic variation 
include dispersed anatomical location of trypanosomes within the host (39), infection-
associated immunosuppression (40), and putative, direct host involvement in the 
switching mechanism (17, 41).  Ordered antigenic variation occurs in the bloodstream 
without complication from parasites in other anatomical niches.  Trypanosoma vivax is 
mainly vascular yet displays order (17), and direct analysis of the distribution and 
exchange of T. brucei variants between vascular and extravascular sites, using VSG-
specific antibodies (39), has refuted the proposal, from indirect studies, that extravascular 
colonies seed the variant pool in the blood (42).  It is clear from empirical analyses of 
>100 variants in >50 host animals that antibody responses against individual variants 
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generally are very persistent, usually lasting for as long as infections are followed (15-
17).  These antibodies are trypanolytic and, consequently, once a variant has arisen it 
does not reappear in long-term infection (15-17).  Hence, immunosuppressive effects 
reported in model hosts (40) are not relevant to antigenic variation, certainly up to the 
terminal stages of infection.  There is another VSG-triggered immune response, which 
activates macrophages to yield trypanocidal agents (38), but it is not known whether this 
response kills trypanosomes variant-specifically.  As this response is mainly 
extravascular (43), and order is not influenced by trypanosomes in that compartment (17, 
39), it is unlikely to be of major influence on order.  Although the anti-trypanosome 
immune response is complex (38), the dynamics of antibody production and variant 
killing strongly correlate, and it is empirical data regarding antibody thresholds upon 
which we base the model.  Hosts are not directly involved in switching, which is parasite-
intrinsic (41) and is independent of host species (17); the host acts solely to select new 
variants by killing old ones. 
 
Here, we have developed a mathematical model incorporating all the influential 
parameters listed above.  To examine how switch rates and patterns influence order, and 
order influences infection probability, initially we test whether the differential-activation 
switching pattern (Fig. 1C) can yield the main elements of realistic infection profiles, 
then we extend our model to test the homology switching pattern for mosaic genes, 
hitherto unincorporated in any trypanosome model (Fig. 1D), but likely to be a major 
influence in chronic infections.  As other parameters have been quantified empirically, 
the only one varied in our model is the switch rate between variants.  Hence, our model 
has the benefits of being more parsimonious, and biologically more realistic, than other 
models.   
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We imagine a population of trypanosomes in which the number of replicative 
(slender) and non-replicative (stumpy, cell cycle arrested) trypanosomes that are variant i 
are given by vi and mi respectively.  The slender cells have an intrinsic growth rate rt, 
where t is time post inoculation and, when a slender cell divides, there is a probability, f, 
that one daughter cell will differentiate to a stumpy cell.  This rate of differentiation 
increases as the total number of parasites increases (33, 34).  The slender cells are also 
able to switch VSG.  We assume that all variants switch off at the same rate, but there are 
differences in the activation rate of different VSGs.  This switching rate we call si,j, which 
is the rate at which variant i is switched to from variant j.  As the host acquires immunity 
to variant i, the slender and stumpy cells will be killed at a rate dependent on the strength 
of the acquired immune response, ai.  The value of ai can be from 0 to 1, where 0 means 
no immune response and 1 means the maximum possible immune response. The 
maximum rates at which the immune system can kill the slender and stumpy cells are d 
and δ respectively.  It is computationally infeasible to process the hundreds or more of 
possible variants, so in all simulations we include a VSG repertoire of 30.  While this 
clearly will abbreviate simulated infections, it will not influence what is being tested, the 
patterns of variants in peaks.  The simulations all initiate with a single variant, because 
that was the basis of almost all published empirical analyses of infections.      
The dynamics of the slender and stumpy cells are given by: 
dv i
dt






= v i rt f − mi δ ai  
where  
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Here, V is the total number of slender cells in the host, M the total number of 
stumpy cells, and K is the number of cells at which maximum stumpy production occurs.  
At the beginning of infection the growth rate is at a maximum, r, but as the infection 
progresses there is generalised inhibition of growth rate independent of the acquired 
immune response to each of the variants (37).  For all of our simulations we chose a ρ 
value of 2500, based on the observation that it takes approximately 26 days for growth to 
be inhibited by 50% (37).  Other parameters used in all simulations are n=30, r=0.1.h
-1
 
(44), d=0.5.h-1 and δ=0.1.h-1 (45), and K=1x108 (33). 
When modelling the impact of the immune response on infection dynamics, it is 
most important to capture the dynamics of parasite removal, which can be done without 
making detailed assumptions about underlying mechanisms.  As the kinetics of antibody 
production and variant killing strongly correlate, it is antibody empirical data upon which 

















- where ci (which determines the maximum rate at which the immune response can 
increase against variant i), C (a scaling factor) and x (rate of growth of the response) are 
constants, and the prime indicates the number of cells at time t-τ, where τ is the time it 
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takes for the immune system to respond .  For all simulations ci = 100 and C=1x10
8
.  The 
immune response against variant i grows at an intrinsic rate determined by the number of 
cells of variant i.  The intrinsic growth rate of the immune response x leads to a threshold 
of effectiveness, above which there is killing of the parasite, as occurs in vivo (46, 47).  
Whether trypanosomes can resist antibodies during switching or at low antibody levels 
(24, 48) would be included in these empirical profiles of immunity and do not need to be 
factored.  Another generality based on evidence (14, 15) is that immune responses are 
very persistent. 
To establish the basic behaviour of the model independently of differential 
switching, initially we incorporated a uniform switching pattern (Fig. 1A), where the 
probability of switching to another (or the same) variant, and the probability of each of 
the variants being switched on, is 0.01 per population doubling (49).  One consequence of 
switching is that there is constant regeneration of previously expressed variants, and their 
rapid elimination by existing antibodies.  This is included in our model but has negligible 
effect on overall population dynamics, because only 1% of the population is switching at 
any time and therefore only 1% of the population is potentially vulnerable to these 
existing antibodies at any time.  As expected, the VSG repertoire is quickly exhausted, 
there is no order in expression, and the infection is quickly eliminated by the host 
immune system (Fig. 2).  To investigate the effect of differential switching, we next 
assumed the differential-activation pattern shown in Fig. 1C.  Because the activation rate 
of each variant is independent of the currently expressed variant, the value of si,j depends 
only on i and not on j (so for example, s1,1 = s1,2 = s1,3 and so on).  Initially we 
incorporated switch rates from a continuous range, from high to low activation 
probability, with a range of nearly 100,000 fold in the activation rates of different 
variants (once chosen, the switch rates remain constant throughout the simulation).  This 
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range may or may not reach the lowest VSG switch rate, which is unknown, but a wider 
range of activation probabilities would simply extend the chronicity of infection.  Figure 
3A reveals order in variants and in the corresponding immune responses.  During the first 
peak of parasitaemia, the inoculated variant type predominates, with different variants 
being generated continually, according to their inherent activation rate.  The first immune 
response removes the infecting variant, allowing the next variant to become more 
predominant, and the cycle of growth and death repeats for all variants.  Superimposed on 
this is higher-level fluctuation of the whole parasitaemia, resulting from the density-
dependent differentiation from long slender to short stumpy, non-dividing, stage (34).  
The general features of these initial simulations resemble what occurs in vivo (15, 16): no 
variants reappeared, there was positive correlation between activation time of each 
variant and the appearance of a strong antibody response, many variants were present 
simultaneously, and the parasitaemia occurred in waves.  Thus, differential activation 
probabilities clearly can be a major factor in determining order, which does not require a 
complex switch matrix in which the activation probability depends on the VSG being 
expressed. 
We then tested whether discontinuous switch rate changes, corresponding to the 
early and later groups in vivo (16), yield realistic patterns of antigenic variation and 
parasitaemia.  Using the differential-activation switching pattern (Fig. 1C), we included a 
faster and a slower group of 15 variants each for the second set of simulations (Fig. 3B).  
The third set of simulations included 10 variants each assigned to high, medium and low 
activation probabilities (Fig. 3C).  Both the second and third sets of simulations produced 
more distinct parasitaemia peaks and more prominent variant sub-peaks (Figs 3B, 3C) 
than the first set of simulations (Fig 3A).  As the number of switch rate distributions 
increases, there is a progressive clustering of the variant-specific immune responses, 
tending towards what has been observed to occur in vivo (15, 32, 50).   
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To examine the influence of mosaic-activated switching, whereby the extent of 
homology with the coding sequence of the active VSG determines likelihood of 
participation in the switch, we modelled it in isolation, with the assumptions that 
switching is reversible and that VSG 1 was most homologous to 2, which in turn was 
most and equally homologous to 1 and 3, etcetera (si,j = sj,i for all i and j) (Fig. 1D).  Our 
simulations of homology based switching yield, within each relapse peak, several variant 
sub-peaks and ordered progression (Fig. 4).  Finally, to model the in vivo situation, we 
combined differential-activation and homology-dependent switching (Fig. 1C, 1D).  
Fifteen variants were allocated to each switch mechanism (Fig. 5), with the flank-
activated VSGs having an activation rate between one and five orders of magnitude 
higher than the mosaic VSGs.  These simulations produce the same general features as 
both previous series, and patterns strongly resembling what occurs in vivo (32).   
It is clear from all of the discontinuous rate range simulations (Figs 3-5) that 
intrinsic VSG activation rates can provide order in antigenic variation, and that the 
switching distribution has a strong influence on antigenic variation patterns.  A patent 
prediction is that the characteristic groupings of variants in each parasitaemia peak in 
vivo (15, 16) arise primarily from the existence of discontinuous switch ranges.  
Superimposed on this are the combined effects of density-dependent differentiation to the 
stumpy stage and immune responses, which result in aggregation of more variants within 
growth peaks and greater spacing between peaks.  A challenge is to search for these 
putative VSG groupings, which are on a finer scale than those proposed by Capbern et al 
(16), and then to determine their molecular basis. 
Thus, two main factors, both parasite-determined, can account for ordered antigenic 
variation in chronic infection.  They are simple variation in activation rates and 
differentiation to the non-dividing transmission stage.  Our model is thus more 
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parsimonious than previous theoretical models and more consistent with experimental 
data (see discussion above).  It can be argued that both differential activation probabilities 
and density-dependent differentiation apply generally to antigenic variation in eukaryotic 
parasites.  Stochastic, ordered switching is held to be common to bacterial and eukaryotic 
pathogens (51, 52).  Density-dependent differentiation to a non-dividing stage, while not 
evident in bacteria, is well documented in eukaryotic parasites.  An interesting case is 
Giardia, which encysts with density dependence and appears to produce new antigenic 
variants upon excystation (53).  Nevertheless, trypanosome antigenic variation differs 
from that of other pathogens in its likely scale, the repertoire consisting of up to 2000 
VSG genes, the majority of which are pseudogenes.  In contrast, the silent MSP2 archive 
of the bacterium A. marginale comprises just five pseudogenes (6), while the P. 
falciparum var archive has about 60 members (54).  The trypanosome archive may have 
enlarged so much because, unlike the variable antigens of other pathogens, the VSG 
appears not to have biochemical function, presumably allowing more unrestrained, 
diversifying evolution.  The combinatorial use of damaged genes to create novel, 
expressed mosaic genes can greatly enlarge the effective archive, as seen with A. 
marginale (6), so T. brucei theoretically has strikingly enormous potential, with 
corresponding capability for lengthening infection (55).   
There may be two reasons for the possible silent information overload.  One is that 
African trypanosomes live permanently extracellularly in the vasculature, provoking 
extensive antibody responses.  The other relates to rate of archive use.  In our analysis, 
the experimental set of 30 VSGs was expended in only two or three peaks.  This is more 
profligate than generally has been concluded from empirical clonal studies, but those 
studies screened only a few selected VSGs, in unusually slowly switching strains (14, 22, 
36).  Nevertheless, profligacy of similar magnitude has been recorded in the first relapse 
after the more natural situation, tsetse fly transmission (56).  It might be concluded that 
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trypanosome antigenic variation appears effectively to be pitched in a war of attrition 
with the host antibody responses, the two systems attempting to match the rapid 
diversification of each other.  By simple force of numbers, trypanosome antigenic 
variation apparently does not require the subtleties, such as transient cross-reactive 
immune responses, that have been hypothesised for Plasmodium (30).  An important 
consequence of order being determined by the trypanosome, rather than the host, is that 
distinct series, or ‘strings’, of variants can be generated in different infections with the 
same strain, due to the stochastic nature of mosaic gene formation.  This might enable 
effective transmission in the face of herd immunity (57).  
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Different suggested switching patterns.  The green, red and blue shapes represent 
trypanosomes expressing different VSG genes.  The values u, v, w, x, y and z represent 
switching rates.  A.  Uniform switching pattern; all variants are switched to and from at 
the same rate.  B.  Interdependent switching pattern, associated with direction of switch; 
the rate that a variant is switched to depends on the variant it is switching from.  The rate 
depends on the direction of the switching so that, for example, the rate that red switches 
to blue is not the same as the rate that blue switches to red.  This is the switching pattern 
used by Frank (35).  C.  Differential activation switching pattern; each variant has a 
distinct activation rate, independent of the variant it is replacing so that, for example, the 
rate that red switches to blue is equal to the rate that green switches to blue.  D.  
Interdependent switching not associated with switch direction, as occurs in homology-
dependent (mosaic) switching.  The rate that a variant is switched to depends on the 
variant switched from.  The rate does not depend on the direction of switching so that, for 
example, the rate that red switches to blue is equal to the rate that blue switches to red. 
 
Figure 2 
Time series of parasite dynamics and the immune response with a uniform switching 
pattern.  All variants have equal probability of switching to any other variant, so that the 
probability that any parasite switches to another variant, or that any variant is switched to, 
is 0.01 per population doubling.  The top panel shows the parasite numbers; the black line 
shows the total number of parasites, and each coloured line represents a variant.  Only 
one line is visible because the trajectories of all but the inoculating variant overlap.  The 
bottom panel shows the immune response against each variant.  Apart from the 
inoculating variant, the trajectories of the immune response against each of the variants 
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are identical.  The factors influencing growth are multiplication rate, non-specific growth 
inhibition (37), switching between variants and the density dependent variables of 
differentiation to the non-proliferating stumpy stage (33), immune response onset (46, 
47) and removal of variants.  The simulation began with 1000 trypanosomes (akin to 
natural transmissions from tsetse), and involve a computationally feasible archive of 30 
VSGs; the output provides a sample of events, rather than simulating an entire infection.   
The parameters are: n=30, r=0.1.h-1, d=0.5.h-1 and δ= 0.1.h-1, K=1x108, ρ=2500, ci=100, 
C=1x10
8




Time series of parasite dynamics and the immune response with a differential-activation 
switching pattern.  The rate at which variants are switched to varies, but is independent of 
which variant it is replacing.  The top graphs show the distribution from which the 
switching rates were chosen prior to the simulation.  These rates were re-scaled so that 
the probability that a parasite switches to another, or the same, variant is 0.01 per 
population doubling.  In the middle panels, black lines show the total number of 
parasites, and each coloured line represents a variant.  Bottom panels show the immune 
response against each variant.  Simulations begin with 1000 trypanosomes and a 
repertoire of 30 VSGs.  As this is a small proportion of the potential in vivo repertoire 
(approximately 2000 VSGs), duration of simulated infections is much briefer than occurs 
in vivo.  Parameters are as in Fig. 2.  A.  All variants are chosen from the same 
distribution.  B.  15 of the variants are chosen from the left distribution, 15 from the right.  




Time series of the parasite dynamics and the immune response with a homology-based 
switching pattern.  The rate that a VSG is switched to is dependent on its homology with 
the VSG it is replacing.  It is assumed (12, 13) that VSGs with the closest homology are 
more likely to switch to each other.  For example, VSGs 1 and 2 have very high 
homology, whereas 1 and 30 have the lowest homology.  A total of 30 switching rates 
were chosen randomly from the distribution shown at the top.  The highest switching rate 
determines the rate that a variant switches to itself, si,i.  The next highest switching rate 
determines the rate that VSGs with the closest homology switch to each other, si,i(+or-)1, 
and so on.  Once all the switching rates are chosen they are rescaled so that the 
probability that a parasite switches to another, or the same, variant is 0.01 per population 
doubling.  Parameters used are as in Fig. 2. 
 
Figure 5 
Time series of the parasite dynamics and the immune response where there are two 
classes of variant, those with a differential activation switching pattern and those with a 
homology switching pattern.  The homology of the 30 VSGs was determined by randomly 
drawing switch rates from the left hand distribution shown at the top.  Fifteen of these 
variants were then randomly allocated to the class of variants whose switch rate is 
independent of what variant they are replacing.  Their switch rates were randomly chosen 
from the right hand distribution.  Parameters used are as in Fig. 2. 
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